The current PE ratio of PFE cannot be calculated, as the latest EPS of -$0.05 is negative. Pfizer's last PE ratio on record was 75.76 in December 2023.
The mean historical PE ratio of Pfizer over the last ten years is 19.6. Looking back at the last ten years, PFE's PE ratio peaked in the Dec 2023 quarter at 75.76, with a price of $28.79 and an EPS of $0.38. The Apr 2023 quarter marked the lowest point at 7.89, with a price of $40.8 and an EPS of $5.17.
Maximum annual increase: 726.17% in 2023
Maximum annual decrease: -63.13% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 75.76 | 726.17% |
| 2022 | 9.17 | -39.11% |
| 2021 | 15.06 | -32.5% |
| 2020 | 22.31 | 64.04% |
| 2019 | 13.6 | -40.79% |
| 2018 | 22.97 | 126.31% |
| 2017 | 10.15 | -63.13% |
| 2016 | 27.53 | -3.64% |
| 2015 | 28.57 | 32.09% |
| 2014 | 21.63 | 128.16% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| NVS Novartis AG | 13.96 | $225.1B |
| ABT Abbott Laboratories | 32.58 | $183.08B |
| AZN Astrazeneca plc | 37.57 | $242.23B |
| AMGN Amgen Inc | 47.58 | $179.67B |
| LLY ELI LILLY & Co | 117.98 | $764.72B |
| MRK Merck & Co Inc | 137.65 | $317.26B |
| BMY Bristol Myers Squibb Co | N/A | $102.27B |
| PFE Pfizer Inc | N/A | $174.36B |
The current price to earnings ratio of PFE cannot be determined, as its EPS of -$0.05 is negative.
The average PE ratio for PFE stock over the past 3 years is 17.77.
The average PE ratio for PFE stock over the past 5 years is 17.35.
Over the last ten years, the quarterly PE ratio reached its highest level at 75.76 in the Dec 2023 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.